Examining the relationships between invention disclosure type in industry and academia and geographical disclosure trends, using plant-made pharmaceuticals as a single-sector model for the biopharmaceutical industry.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Thursby, J.G. & Thursby, M.C. Science. 301, 1052 (2003).
Crespi, R.S. Trends Biotechnol. 16, 450–455 (1998).
Ma, J.K. et al. EMBO Rep. 6, 593–599 (2005).
Roland Berger Market Research for the European Patent Office. Study on the Cost of Patenting (EPO, 2004).
The next Viagra. Investors Chronicle 16–18 (11–17 July 2008).
Hall, S. & Wood, A.J.J. The Scientist 30–36 (August 2008).
Webster, P. Plants as factories: a manufacturing solution for the biopharmaceutical industry? Innovations Pharmaceut. Technol. (2005). http://www.iptonline.com/articles/public/IPT_16_2005_p64_66x.pdf
Parida, D.K., Mehdiratta, R. & Saberwal, G. Nat. Biotechnol. 26, 763–766 (2008).
World Intellectual Property Organization. World patent report: a statistical review (WIPO, Geneva, 2008). http://www.wipo.int/ipstats/en/statistics/patents/wipo_pub_931.html
Marks & Clerk. Academia outpaces corporate biotechnology, but Europe lags behind US and Asia. Marks and Clerk Biotechnology Report (2007).
Analyzing global patenting activity using strategic intelligence and competitive analysis information. World IP Today Report (Thomson Reuters, 2008).
Yiannaka, A. & Fulton, M. Intl. J. Ind. Organ. 24, 177–202 (2006).
von Gabain, A. & Lanthaler, W. EMBO Rep. 4, 642–646 (2003).
Geuna, A. & Nesta, L.J.J. Res. Policy 35, 790–807 (2006).
Royle, M., Morgan, G. & Cohen, S. Bio directive fails to unify European law. Gen. Eng. News (September 2008).
Jensen, P.H., Palangkaraya, A. & Webster, E. Application pendency times and outcomes across four patent offices. Intellectual Property Research Institute of Australia/Melbourne Institute Working Paper No. 01/08, ISSN 1447-2317 (IPRIA, Melbourne, Australia, 2008). http://www.ipria.org/publications/wp/2008/IPRIAWP01.2008.pdf
Acknowledgements
This research was performed through an EU Framework Programme 6 grant–Pharma-Planta project and with support from the Sir Joseph Hotung Endowment Fund. We wish to thank L. Nelsen, E. Nettleton and R. Mahoney for critical reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thangaraj, H., van Dolleweerd, C., McGowan, E. et al. Dynamics of global disclosure through patent and journal publications for biopharmaceutical products. Nat Biotechnol 27, 614–618 (2009). https://doi.org/10.1038/nbt0709-614
Issue Date:
DOI: https://doi.org/10.1038/nbt0709-614
This article is cited by
-
Analysing patent landscapes in plant biotechnology and new plant breeding techniques
Transgenic Research (2013)